183 related articles for article (PubMed ID: 3019836)
1. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector.
Hammarskjöld ML; Wang SC; Klein G
Gene; 1986; 43(1-2):41-50. PubMed ID: 3019836
[TBL] [Abstract][Full Text] [Related]
2. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
Lupton S; Levine AJ
Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
[TBL] [Abstract][Full Text] [Related]
3. Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA.
Shimizu N; Yamaki M; Sakuma S; Ono Y; Takada K
Int J Cancer; 1988 May; 41(5):744-51. PubMed ID: 2835324
[TBL] [Abstract][Full Text] [Related]
4. Identification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes.
Hearing JC; Nicolas JC; Levine AJ
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4373-7. PubMed ID: 6087322
[TBL] [Abstract][Full Text] [Related]
5. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
Rymo L; Klein G; Ricksten A
Proc Natl Acad Sci U S A; 1985 May; 82(10):3435-9. PubMed ID: 2987926
[TBL] [Abstract][Full Text] [Related]
6. Immunoprecipitation of Epstein-Barr virus EBNA1 protein using human polyclonal serum.
Wang SC; Hammarskjöld ML; Klein G
J Virol Methods; 1986 Jul; 13(4):323-32. PubMed ID: 3018021
[TBL] [Abstract][Full Text] [Related]
7. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
8. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
[TBL] [Abstract][Full Text] [Related]
9. Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.
Ricksten A; Svensson C; Welinder C; Rymo L
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2407-18. PubMed ID: 2821180
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus expressing Epstein-Barr virus nuclear antigen 1.
Hummel M; Arsenakis M; Marchini A; Lee L; Roizman B; Kieff E
Virology; 1986 Jan; 148(2):337-48. PubMed ID: 3002038
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector.
Joab I; Rowe DT; Bodescot M; Nicolas JC; Farrell PJ; Perricaudet M
J Virol; 1987 Oct; 61(10):3340-4. PubMed ID: 3041055
[TBL] [Abstract][Full Text] [Related]
12. Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.
Polvino-Bodnar M; Shedd D; Miller G
J Virol; 1986 May; 58(2):324-30. PubMed ID: 3009849
[TBL] [Abstract][Full Text] [Related]
13. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
Reisman D; Sugden B
Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
[TBL] [Abstract][Full Text] [Related]
14. BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.
Ricksten A; Kallin B; Alexander H; Dillner J; Fåhraeus R; Klein G; Lerner R; Rymo L
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):995-9. PubMed ID: 2829223
[TBL] [Abstract][Full Text] [Related]
15. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins.
Welinder C; Larsson NG; Szigeti R; Ehlin-Henriksson B; Henle G; Henle W; Klein G; Ricksten A; Rymo L; Sulitzeanu D
Int J Cancer; 1987 Sep; 40(3):389-95. PubMed ID: 3040603
[TBL] [Abstract][Full Text] [Related]
16. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
17. Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene.
Robert MF; Shedd D; Weigel RJ; Fischer DK; Miller G
J Virol; 1984 Jun; 50(3):822-31. PubMed ID: 6328012
[TBL] [Abstract][Full Text] [Related]
18. [Construction and immunological responses of recombinant adenovirus containing Epstein-Barr nuclear antigen 1 in mice].
Tong YY; Li HX; Zhang LX; Wang Z; Zhou L; Zeng Y; Du HJ
Bing Du Xue Bao; 2014 Jul; 30(4):429-35. PubMed ID: 25272599
[TBL] [Abstract][Full Text] [Related]
19. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
20. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
Ricksten A; Olsson A; Andersson T; Rymo L
Nucleic Acids Res; 1988 Sep; 16(17):8391-410. PubMed ID: 2843816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
